Breaking News on Global Pharmaceutical Technology & Manufacturing

Headlines > Regulatory & Safety

News in brief

Isis opens new Cali R&D site

21-Sep-2011

Related topics: Regulatory & Safety

US drug maker Isis Pharmaceuticals has opened a new R&D centre in Carlsbad, California designed to forge closer interdisciplinary bonds.

The firm said the new 176,000sqft building in Gazelle Court in the Carlsbad Oaks North Business Park in Carlsbad consolidates its R&D operations in a single site that will foster a more collaborative between its discovery and drug development teams.

 

Isis CEO Stanley Crooke said: "Completed ahead of schedule and below budget by BioMed, our real estate partner since 2005, our new corporate home provides the ideal environment for us to continue to innovate and create the medicines of tomorrow.